Search Orphan Drug Designations and Approvals
-
Generic Name: | peptides mimicking antigen receptors on autoimmune B cells and autoimmune T cells associated with myasthenia gravis |
---|---|
Date Designated: | 02/04/2011 |
Orphan Designation: | Treatment of myasthenia gravis |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
CuraVac Europe SA Avenue de Villefranche Rixensart Belgium The sponsor address listed is the last reported by the sponsor to OOPD. |
-